_id
691728df3c536f8df2316cd3
Ticker
VINC
Name
Vincerx Pharma, Inc. Common Stock
Exchange
NASDAQ
Address
1825 S. Grant Street, San Mateo, CA, United States, 94402
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://vincerx.com
Description
Vincerx Pharma, Inc. operates as a clinical-stage biopharmaceutical company that develops differentiated and novel therapies to address the unmet medical needs of patients with cancer in the United States. Its VersAptx bioconjugation platform combines different targeting, linker, and payload technologies to develop antibody-drug conjugates (ADC) and small molecule drug conjugates (SMDC); and provides CellTrapper technology for use in reduction of payload cellular permeability. The company develops VIP943, an antibody drug conjugate in Phase 1 dose-escalation study for relapsed/refractory acute myeloid leukemia, higher-risk MDS, and B-cell acute lymphoblastic leukemia; VIP236, an SMDC, which is in Phase 1 dose-escalation study for the treatment of patients with advanced or metastatic solid tumors; and VIP924, an anti-CXCR5 ADC that leverages the same effector chemistry in preclinical studies for b-cell malignancies. It has a collaboration with the National Institutes of Health for the Phase 1 dose-escalation of enitociclib, a highly selective cyclin-dependent kinase 9 inhibitor. The company was formerly known as Vincera Pharma, Inc. and changed its name to Vincerx Pharma, Inc. in January 2021. Vincerx Pharma, Inc. was founded in 2019 and is headquartered in San Mateo, California.
Last Close
0.012
Volume
4000
Current Price
0.012
Change
0
Last Updated
2025-12-05T13:25:31.573Z
Image
https://logo.clearbit.com/vincerx.com
Ipo Date
2020-05-27T00:00:00.000Z
Market Cap
26171
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Rating
4.5
Target Price
200
Strong Buy
1
Buy
1
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-03-31
Revenue
0
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
3334000
Operating Income
-3334000
Interest Expense
-
Pretax Income
-5000000
Net Income
-5000000
Eps
-0.9552414000094378
Dividends Per Share
-
Shares Outstanding
5234277
Income Tax Expense
-
EBITDA
-3334000
Operating Margin
-
Total Other Income Expense Net
-1666000
Cash
4437000
Short Term Investments
-
Receivables
-
Inventories
-
Total Current Assets
4686000
Property Plant Equipment
-
Total Assets
4686000
Payables
2269000
Short Term Debt
-
Long Term Debt
-
Total Liabilities
2620000
Equity
2066000
Depreciation
0
Change In Working Capital
-1619000
Cash From Operations
-4454000
Capital Expenditures
0
Cash From Investing
-
Cash From Financing
3856000
Net Change In Cash
-547000
PE
-
PB
0.030402394966118105
ROE
-242.01355275895452
ROA
-106.70081092616303
FCF
-4454000
Fcf Percent
-
Piotroski FScore
1
Health Score
32
Deep Value Investing Score
5
Defensive Investing Score
6
Dividend Investing Score
1.5
Economic Moat Investing Score
2.8
Garp Investing Score
1.5
Growth Investing Score
1
Momentum Investing Score
2.5
Net Net Investing Score
8
Quality Investing Score
1.5
Value Investing Score
5.5
Quarters > 0 > quarter
2025-03-31
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
3334000
Quarters > 0 > income Statement > operating Income
-3334000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-5000000
Quarters > 0 > income Statement > net Income
-5000000
Quarters > 0 > income Statement > eps
-0.9552414000094378
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
5234279
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-3334000
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
-1666000
Quarters > 0 > balance Sheet > cash
4437000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
4686000
Quarters > 0 > balance Sheet > property Plant Equipment
-
Quarters > 0 > balance Sheet > total Assets
4686000
Quarters > 0 > balance Sheet > payables
2269000
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
2620000
Quarters > 0 > balance Sheet > equity
2066000
Quarters > 0 > cash Flow > net Income
-5000000
Quarters > 0 > cash Flow > depreciation
0
Quarters > 0 > cash Flow > change In Working Capital
-1619000
Quarters > 0 > cash Flow > cash From Operations
-4454000
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
3856000
Quarters > 0 > cash Flow > net Change In Cash
-547000
Quarters > 0 > ratios > PE
-0.9552414000094378
Quarters > 0 > ratios > PB
0.030402394966118105
Quarters > 0 > ratios > ROE
-242.01355275895452
Quarters > 0 > ratios > ROA
-106.70081092616303
Quarters > 0 > ratios > FCF
-4454000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
32
Quarters > 1 > quarter
2024-12-31
Quarters > 1 > income Statement > revenue
1068000
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
534000
Quarters > 1 > income Statement > operating Expenses
8826000
Quarters > 1 > income Statement > operating Income
-8826000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-7994000
Quarters > 1 > income Statement > net Income
-7994000
Quarters > 1 > income Statement > eps
-1.527239950335089
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
5234279
Quarters > 1 > income Statement > income Tax Expense
-220724
Quarters > 1 > income Statement > EBITDA
-8545000
Quarters > 1 > income Statement > operating Margin
-826.4044943820224
Quarters > 1 > income Statement > total Other Income Expense Net
832000
Quarters > 1 > balance Sheet > cash
4987000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
1041000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
6410000
Quarters > 1 > balance Sheet > property Plant Equipment
0
Quarters > 1 > balance Sheet > total Assets
8005000
Quarters > 1 > balance Sheet > payables
2029000
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
5281000
Quarters > 1 > balance Sheet > equity
2724000
Quarters > 1 > cash Flow > net Income
-7994000
Quarters > 1 > cash Flow > depreciation
281000
Quarters > 1 > cash Flow > change In Working Capital
1454000
Quarters > 1 > cash Flow > cash From Operations
-6181000
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
7175000
Quarters > 1 > cash Flow > cash From Financing
985000
Quarters > 1 > cash Flow > net Change In Cash
2039000
Quarters > 1 > ratios > PE
-1.527239950335089
Quarters > 1 > ratios > PB
0.02305849779735683
Quarters > 1 > ratios > ROE
-293.4654919236417
Quarters > 1 > ratios > ROA
-99.8625858838226
Quarters > 1 > ratios > FCF
-6181000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-5.787453183520599
Quarters > 1 > health Score
24
Quarters > 2 > quarter
2024-09-30
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
-
Quarters > 2 > income Statement > operating Expenses
7793000
Quarters > 2 > income Statement > operating Income
-7793000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-7843000
Quarters > 2 > income Statement > net Income
-7843000
Quarters > 2 > income Statement > eps
-1.4085918535509876
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
5567972
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-7518000
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
-50000
Quarters > 2 > balance Sheet > cash
2942000
Quarters > 2 > balance Sheet > short Term Investments
7144000
Quarters > 2 > balance Sheet > receivables
1063000
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
11748000
Quarters > 2 > balance Sheet > property Plant Equipment
1516000
Quarters > 2 > balance Sheet > total Assets
14947000
Quarters > 2 > balance Sheet > payables
1963000
Quarters > 2 > balance Sheet > short Term Debt
1274000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
5839000
Quarters > 2 > balance Sheet > equity
9108000
Quarters > 2 > cash Flow > net Income
-7843000
Quarters > 2 > cash Flow > depreciation
275000
Quarters > 2 > cash Flow > change In Working Capital
-451000
Quarters > 2 > cash Flow > cash From Operations
-6379000
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
1374000
Quarters > 2 > cash Flow > cash From Financing
0
Quarters > 2 > cash Flow > net Change In Cash
-4978000
Quarters > 2 > ratios > PE
-1.4085918535509876
Quarters > 2 > ratios > PB
0.007335931488801054
Quarters > 2 > ratios > ROE
-86.11111111111111
Quarters > 2 > ratios > ROA
-52.472067973506384
Quarters > 2 > ratios > FCF
-6379000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
38
Quarters > 3 > quarter
2024-06-30
Quarters > 3 > income Statement > revenue
0
Quarters > 3 > income Statement > cost Of Revenue
270000
Quarters > 3 > income Statement > gross Profit
-270000
Quarters > 3 > income Statement > operating Expenses
7366000
Quarters > 3 > income Statement > operating Income
-7366000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-1808000
Quarters > 3 > income Statement > net Income
-1808000
Quarters > 3 > income Statement > eps
-0.32471427658041385
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
5567972
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-7096000
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
5558000
Quarters > 3 > balance Sheet > cash
7923000
Quarters > 3 > balance Sheet > short Term Investments
8396000
Quarters > 3 > balance Sheet > receivables
1018000
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
18283000
Quarters > 3 > balance Sheet > property Plant Equipment
1791000
Quarters > 3 > balance Sheet > total Assets
21527000
Quarters > 3 > balance Sheet > payables
1536000
Quarters > 3 > balance Sheet > short Term Debt
2472000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
6079000
Quarters > 3 > balance Sheet > equity
15448000
Quarters > 3 > cash Flow > net Income
-1808000
Quarters > 3 > cash Flow > depreciation
270000
Quarters > 3 > cash Flow > change In Working Capital
125000
Quarters > 3 > cash Flow > cash From Operations
-5828000
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-8337000
Quarters > 3 > cash Flow > cash From Financing
17002000
Quarters > 3 > cash Flow > net Change In Cash
2813000
Quarters > 3 > ratios > PE
-0.32471427658041385
Quarters > 3 > ratios > PB
0.00432519834282755
Quarters > 3 > ratios > ROE
-11.70378042465044
Quarters > 3 > ratios > ROA
-8.39875505179542
Quarters > 3 > ratios > FCF
-5828000
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
41
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
-
Annuals > 0 > income Statement > gross Profit
-
Annuals > 0 > income Statement > operating Expenses
31463000
Annuals > 0 > income Statement > operating Income
-31463000
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-30074000
Annuals > 0 > income Statement > net Income
-30074000
Annuals > 0 > income Statement > eps
-5.745585972776766
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
5234279
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-31463000
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
1389000
Annuals > 0 > balance Sheet > cash
4987000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
1041000
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
6410000
Annuals > 0 > balance Sheet > property Plant Equipment
0
Annuals > 0 > balance Sheet > total Assets
8005000
Annuals > 0 > balance Sheet > payables
2029000
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
5281000
Annuals > 0 > balance Sheet > equity
2724000
Annuals > 0 > cash Flow > net Income
-30074000
Annuals > 0 > cash Flow > depreciation
1090000
Annuals > 0 > cash Flow > change In Working Capital
-178000
Annuals > 0 > cash Flow > cash From Operations
-26127000
Annuals > 0 > cash Flow > capital Expenditures
0
Annuals > 0 > cash Flow > cash From Investing
212000
Annuals > 0 > cash Flow > cash From Financing
17992000
Annuals > 0 > cash Flow > net Change In Cash
-7788000
Annuals > 0 > ratios > PE
-5.745585972776766
Annuals > 0 > ratios > PB
0.02363496024229075
Annuals > 0 > ratios > ROE
-1104.0381791483114
Annuals > 0 > ratios > ROA
-375.6901936289819
Annuals > 0 > ratios > FCF
-26127000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
23
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
915000
Annuals > 1 > income Statement > gross Profit
-915000
Annuals > 1 > income Statement > operating Expenses
41694000
Annuals > 1 > income Statement > operating Income
-42609000
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-40157000
Annuals > 1 > income Statement > net Income
-40157000
Annuals > 1 > income Statement > eps
-6.837902861491302
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
5872707
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-39242000
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
2452000
Annuals > 1 > balance Sheet > cash
12782000
Annuals > 1 > balance Sheet > short Term Investments
0
Annuals > 1 > balance Sheet > receivables
1044000
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
14733000
Annuals > 1 > balance Sheet > property Plant Equipment
2326000
Annuals > 1 > balance Sheet > total Assets
18217000
Annuals > 1 > balance Sheet > payables
2497000
Annuals > 1 > balance Sheet > short Term Debt
1162000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
6995000
Annuals > 1 > balance Sheet > equity
11222000
Annuals > 1 > cash Flow > net Income
-40157000
Annuals > 1 > cash Flow > depreciation
915000
Annuals > 1 > cash Flow > change In Working Capital
-4191000
Annuals > 1 > cash Flow > cash From Operations
-40453000
Annuals > 1 > cash Flow > capital Expenditures
0
Annuals > 1 > cash Flow > cash From Investing
41500000
Annuals > 1 > cash Flow > cash From Financing
114000
Annuals > 1 > cash Flow > net Change In Cash
1121000
Annuals > 1 > ratios > PE
-6.837902861491302
Annuals > 1 > ratios > PB
0.0064368469167706294
Annuals > 1 > ratios > ROE
-357.84173944038497
Annuals > 1 > ratios > ROA
-220.43695449305596
Annuals > 1 > ratios > FCF
-40453000
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
30
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
939000
Annuals > 2 > income Statement > gross Profit
-939000
Annuals > 2 > income Statement > operating Expenses
71105000
Annuals > 2 > income Statement > operating Income
-68722000
Annuals > 2 > income Statement > interest Expense
8207000
Annuals > 2 > income Statement > pretax Income
-62984000
Annuals > 2 > income Statement > net Income
-65367000
Annuals > 2 > income Statement > eps
-11.271435591919785
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
5799350
Annuals > 2 > income Statement > income Tax Expense
-8207000
Annuals > 2 > income Statement > EBITDA
-62045000
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
5738000
Annuals > 2 > balance Sheet > cash
11663000
Annuals > 2 > balance Sheet > short Term Investments
40796000
Annuals > 2 > balance Sheet > receivables
1372000
Annuals > 2 > balance Sheet > inventories
-1238000
Annuals > 2 > balance Sheet > total Current Assets
55964000
Annuals > 2 > balance Sheet > property Plant Equipment
3241000
Annuals > 2 > balance Sheet > total Assets
59286000
Annuals > 2 > balance Sheet > payables
4065000
Annuals > 2 > balance Sheet > short Term Debt
2048000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
11618000
Annuals > 2 > balance Sheet > equity
47668000
Annuals > 2 > cash Flow > net Income
-65367000
Annuals > 2 > cash Flow > depreciation
939000
Annuals > 2 > cash Flow > change In Working Capital
-1020000
Annuals > 2 > cash Flow > cash From Operations
-59604000
Annuals > 2 > cash Flow > capital Expenditures
0
Annuals > 2 > cash Flow > cash From Investing
-40578000
Annuals > 2 > cash Flow > cash From Financing
280000
Annuals > 2 > cash Flow > net Change In Cash
-99831000
Annuals > 2 > ratios > PE
-11.271435591919785
Annuals > 2 > ratios > PB
0.0014964337710833262
Annuals > 2 > ratios > ROE
-137.12973063690526
Annuals > 2 > ratios > ROA
-110.2570590021253
Annuals > 2 > ratios > FCF
-59604000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
33
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
340000
Annuals > 3 > income Statement > gross Profit
-340000
Annuals > 3 > income Statement > operating Expenses
62656000
Annuals > 3 > income Statement > operating Income
-62656000
Annuals > 3 > income Statement > interest Expense
23350000
Annuals > 3 > income Statement > pretax Income
-39306000
Annuals > 3 > income Statement > net Income
-39306000
Annuals > 3 > income Statement > eps
-8.298050889054261
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
4736775
Annuals > 3 > income Statement > income Tax Expense
-23698000
Annuals > 3 > income Statement > EBITDA
-38966000
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
23350000
Annuals > 3 > balance Sheet > cash
111459000
Annuals > 3 > balance Sheet > short Term Investments
0
Annuals > 3 > balance Sheet > receivables
-
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
111841000
Annuals > 3 > balance Sheet > property Plant Equipment
4182000
Annuals > 3 > balance Sheet > total Assets
117676000
Annuals > 3 > balance Sheet > payables
2019000
Annuals > 3 > balance Sheet > short Term Debt
1476000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
17355000
Annuals > 3 > balance Sheet > equity
100321000
Annuals > 3 > cash Flow > net Income
-39306000
Annuals > 3 > cash Flow > depreciation
340000
Annuals > 3 > cash Flow > change In Working Capital
5609000
Annuals > 3 > cash Flow > cash From Operations
-33402000
Annuals > 3 > cash Flow > capital Expenditures
5258000
Annuals > 3 > cash Flow > cash From Investing
-5258000
Annuals > 3 > cash Flow > cash From Financing
88453000
Annuals > 3 > cash Flow > net Change In Cash
49772000
Annuals > 3 > ratios > PE
-8.298050889054261
Annuals > 3 > ratios > PB
0.000580759088326472
Annuals > 3 > ratios > ROE
-39.180231457022956
Annuals > 3 > ratios > ROA
-33.40188313674836
Annuals > 3 > ratios > FCF
-38660000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
33
Valuation > metrics > PE
-0.9552414000094378
Valuation > metrics > PB
0.030402394966118105
Valuation > final Score
70
Valuation > verdict
97.0% Undervalued
Profitability > metrics > ROE
-242.01355275895452
Profitability > metrics > ROA
-106.70081092616303
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
1.2681510164569216
Risk > metrics > Interest Coverage
-2.0012004801920766
Risk > final Score
22
Risk > verdict
High
Liquidity > metrics > Current Ratio
2.0652269722344645
Liquidity > metrics > Quick Ratio
2.0652269722344645
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
70
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
0
Prev Profitabilities > 1
15
Prev Profitabilities > 2
15
Prev Risks > 0
-34
Prev Risks > 1
-48
Prev Risks > 2
54
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-14T01:23:14.215Z
Earnings History > 0 > period
2025-03-31
Earnings History > 0 > report Date
2025-05-12
Earnings History > 0 > date
2025-03-31
Earnings History > 0 > before After Market
BeforeMarket
Earnings History > 0 > currency
USD
Earnings History > 0 > eps Actual
-3.5694
Earnings History > 0 > eps Estimate
-0.12
Earnings History > 0 > eps Difference
-3.4494
Earnings History > 0 > surprise Percent
-2874.5
Earnings History > 1 > period
2024-12-31
Earnings History > 1 > report Date
2025-03-27
Earnings History > 1 > date
2024-12-31
Earnings History > 1 > before After Market
AfterMarket
Earnings History > 1 > currency
USD
Earnings History > 1 > eps Actual
-15.22
Earnings History > 1 > eps Estimate
-3.4
Earnings History > 1 > eps Difference
-11.82
Earnings History > 1 > surprise Percent
-347.6471
Earnings History > 2 > period
2024-09-30
Earnings History > 2 > report Date
2024-11-12
Earnings History > 2 > date
2024-09-30
Earnings History > 2 > before After Market
BeforeMarket
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-3.4
Earnings History > 2 > eps Estimate
-4.33
Earnings History > 2 > eps Difference
0.93
Earnings History > 2 > surprise Percent
21.4781
Earnings History > 3 > period
2024-06-30
Earnings History > 3 > report Date
2024-08-08
Earnings History > 3 > date
2024-06-30
Earnings History > 3 > before After Market
AfterMarket
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-0.05
Earnings History > 3 > eps Estimate
-0.2
Earnings History > 3 > eps Difference
0.15
Earnings History > 3 > surprise Percent
75
Earnings History > 4 > period
2024-03-31
Earnings History > 4 > report Date
2024-05-14
Earnings History > 4 > date
2024-03-31
Earnings History > 4 > before After Market
AfterMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.58
Earnings History > 4 > eps Estimate
-0.23
Earnings History > 4 > eps Difference
-0.35
Earnings History > 4 > surprise Percent
-152.1739
Earnings History > 5 > period
2023-12-31
Earnings History > 5 > report Date
2024-03-29
Earnings History > 5 > date
2023-12-31
Earnings History > 5 > before After Market
AfterMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.23
Earnings History > 5 > eps Estimate
-0.37
Earnings History > 5 > eps Difference
0.14
Earnings History > 5 > surprise Percent
37.8378
Earnings History > 6 > period
2023-09-30
Earnings History > 6 > report Date
2023-11-14
Earnings History > 6 > date
2023-09-30
Earnings History > 6 > before After Market
BeforeMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.46
Earnings History > 6 > eps Estimate
-0.46
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
0
Earnings History > 7 > period
2023-06-30
Earnings History > 7 > report Date
2023-08-07
Earnings History > 7 > date
2023-06-30
Earnings History > 7 > before After Market
BeforeMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.52
Earnings History > 7 > eps Estimate
-0.6
Earnings History > 7 > eps Difference
0.08
Earnings History > 7 > surprise Percent
13.3333
Earnings History > 8 > period
2023-03-31
Earnings History > 8 > report Date
2023-05-11
Earnings History > 8 > date
2023-03-31
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.68
Earnings History > 8 > eps Estimate
-0.52
Earnings History > 8 > eps Difference
-0.16
Earnings History > 8 > surprise Percent
-30.7692
Earnings History > 9 > period
2022-12-31
Earnings History > 9 > report Date
2023-03-28
Earnings History > 9 > date
2022-12-31
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.65
Earnings History > 9 > eps Estimate
-0.61
Earnings History > 9 > eps Difference
-0.04
Earnings History > 9 > surprise Percent
-6.5574
Earnings History > 10 > period
2022-09-30
Earnings History > 10 > report Date
2022-11-10
Earnings History > 10 > date
2022-09-30
Earnings History > 10 > before After Market
AfterMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.8
Earnings History > 10 > eps Estimate
-0.55
Earnings History > 10 > eps Difference
-0.25
Earnings History > 10 > surprise Percent
-45.4545
Earnings History > 11 > period
2022-06-30
Earnings History > 11 > report Date
2022-08-11
Earnings History > 11 > date
2022-06-30
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.88
Earnings History > 11 > eps Estimate
-0.79
Earnings History > 11 > eps Difference
-0.09
Earnings History > 11 > surprise Percent
-11.3924
Earnings History > 12 > period
2022-03-31
Earnings History > 12 > report Date
2022-05-12
Earnings History > 12 > date
2022-03-31
Earnings History > 12 > before After Market
AfterMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.79
Earnings History > 12 > eps Estimate
-0.76
Earnings History > 12 > eps Difference
-0.03
Earnings History > 12 > surprise Percent
-3.9474
Earnings History > 13 > period
2021-12-31
Earnings History > 13 > report Date
2022-03-29
Earnings History > 13 > date
2021-12-31
Earnings History > 13 > before After Market
BeforeMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.31
Earnings History > 13 > eps Estimate
-0.93
Earnings History > 13 > eps Difference
0.62
Earnings History > 13 > surprise Percent
66.6667
Earnings History > 14 > period
2021-09-30
Earnings History > 14 > report Date
2021-11-12
Earnings History > 14 > date
2021-09-30
Earnings History > 14 > before After Market
BeforeMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-1.39
Earnings History > 14 > eps Estimate
-0.85
Earnings History > 14 > eps Difference
-0.54
Earnings History > 14 > surprise Percent
-63.5294
Earnings History > 15 > period
2021-06-30
Earnings History > 15 > report Date
2021-08-12
Earnings History > 15 > date
2021-06-30
Earnings History > 15 > before After Market
AfterMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.12
Earnings History > 15 > eps Estimate
-0.37
Earnings History > 15 > eps Difference
0.25
Earnings History > 15 > surprise Percent
67.5676
Earnings History > 16 > period
2021-03-31
Earnings History > 16 > report Date
2021-05-17
Earnings History > 16 > date
2021-03-31
Earnings History > 16 > before After Market
BeforeMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.46
Earnings History > 16 > eps Estimate
-0.32
Earnings History > 16 > eps Difference
-0.14
Earnings History > 16 > surprise Percent
-43.75
Earnings History > 17 > period
2020-12-31
Earnings History > 17 > report Date
2021-03-22
Earnings History > 17 > date
2020-12-31
Earnings History > 17 > before After Market
BeforeMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-2.04
Earnings History > 17 > eps Estimate
-
Earnings History > 17 > eps Difference
0
Earnings History > 17 > surprise Percent
-
Earnings History > 18 > period
2020-09-30
Earnings History > 18 > report Date
2020-12-07
Earnings History > 18 > date
2020-09-30
Earnings History > 18 > before After Market
AfterMarket
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.26
Earnings History > 18 > eps Estimate
-
Earnings History > 18 > eps Difference
0
Earnings History > 18 > surprise Percent
-
Earnings History > 19 > period
2020-06-30
Earnings History > 19 > report Date
2020-09-23
Earnings History > 19 > date
2020-06-30
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-0.07
Earnings History > 19 > eps Estimate
-
Earnings History > 19 > eps Difference
0
Earnings History > 19 > surprise Percent
-
Earnings History > 20 > period
2020-03-31
Earnings History > 20 > report Date
2020-05-06
Earnings History > 20 > date
2020-03-31
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-0.01
Earnings History > 20 > eps Estimate
0
Earnings History > 20 > eps Difference
-0.01
Earnings History > 20 > surprise Percent
-
Earnings History > 21 > period
2019-12-31
Earnings History > 21 > report Date
2020-03-03
Earnings History > 21 > date
2019-12-31
Earnings History > 21 > before After Market
-
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-0.002
Earnings History > 21 > eps Estimate
0
Earnings History > 21 > eps Difference
-0.002
Earnings History > 21 > surprise Percent
-
Vincerx Pharma, Inc. operates as a clinical-stage biopharmaceutical company that develops differentiated and novel therapies to address the unmet medical needs of patients with cancer in the United States. Its VersAptx bioconjugation platform combines different targeting, linker, and payload technologies to develop antibody-drug conjugates (ADC) and small molecule drug conjugates (SMDC); and provides CellTrapper technology for use in reduction of payload cellular permeability. The company develops VIP943, an antibody drug conjugate in Phase 1 dose-escalation study for relapsed/refractory acute myeloid leukemia, higher-risk MDS, and B-cell acute lymphoblastic leukemia; VIP236, an SMDC, which is in Phase 1 dose-escalation study for the treatment of patients with advanced or metastatic solid tumors; and VIP924, an anti-CXCR5 ADC that leverages the same effector chemistry in preclinical studies for b-cell malignancies. It has a collaboration with the National Institutes of Health for the Phase 1 dose-escalation of enitociclib, a highly selective cyclin-dependent kinase 9 inhibitor. The company was formerly known as Vincera Pharma, Inc. and changed its name to Vincerx Pharma, Inc. in January 2021. Vincerx Pharma, Inc. was founded in 2019 and is headquartered in San Mateo, California.
Stock Price
$ 0.00
0% decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AVincerx Pharma, Inc. Urges Stockholders to Vote FOR Approval of Dissolution Proposal and Announces Potential Range for Distributions to Stockholders The Manila Times
Read more →VINC stock touches 52-week low at $0.17 amid sharp annual decline Investing.com
Read more →Showing 2 of 10
(Last Updated 2025-03-31)
Rating:
STRONG BUY
Target Price:
$200
Analyst Picks
Strong Buy
1
Buy
1
Hold
0
Sell
0
Strong Sell
0
(Last Updated 2025-03-31)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.08% of the total shares of Vincerx Pharma, Inc. Common Stock
1.
Fidelity Series Total Market Index(0.0433%)
since
2025/07/31
2.
Fidelity Total Market Index(0.0296%)
since
2025/07/31
3.
NT Ext Eq Mkt Indx Fd DC Lend T3(0.0035%)
since
2024/12/31
4.
SSgA U.S. Total Market Index Strategy(0.0016%)
since
2025/03/31
5.
Bank & Trust Co(0.001%)
since
2025/06/30
6.
Fidelity U.S. Equity Index Ins Trust(0.0002%)
since
2025/07/31
7.
Goldman Sachs Group Inc(0%)
since
2025/06/30
8.
State Street Corp(0%)
since
2025/03/31
9.
Rock Springs Capital Management LP(0%)
since
2025/03/31
10.
Susquehanna International Group, LLP(0%)
since
2025/03/31
11.
BlackRock Inc(0%)
since
2025/06/30
12.
Jane Street Group LLC(0%)
since
2025/03/31
13.
Tower Research Capital LLC(0%)
since
2025/06/30
14.
Northern Trust Corp(0%)
since
2025/03/31
15.
Citadel Advisors Llc(0%)
since
2025/06/30
16.
UBS Group AG(0%)
since
2025/06/30
17.
Millennium Management LLC(0%)
since
2025/06/30
18.
SAGE RHINO CAPITAL LLC(0%)
since
2025/06/30
19.
Renaissance Technologies Corp(0%)
since
2025/03/31
20.
Morgan Stanley - Brokerage Accounts(0%)
since
2025/06/30
21.
Vanguard Group Inc(0%)
since
2025/06/30
22.
Geode Capital Management, LLC(0%)
since
2025/06/30
23.
JPMorgan Chase & Co(0%)
since
2025/06/30
24.
Armistice Capital, LLC(0%)
since
2025/03/31
25.
SBI Securities Co Ltd(0%)
since
2025/06/30
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-03-31
EPS Actual
-3.5694
EPS Estimate
-0.12
EPS Difference
-3.4494
Surprise Percent
-2874.5%
(Last Updated 2025-03-31)
(Last Updated 2025-03-31)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-03-31)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-03-31)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.